• Dr. Joyal, a licensed physician with board certifications in Anesthesiology, Pain Medicine, and Addiction Medicine, will oversee the Company's clinical practices and develop program protocols for pain management

SALT LAKE CITY, UT / ACCESSWIRE / August 29, 2024 / KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, today announced it appointed Jeremy Joyal, MD, as Medical Director, where he will oversee the Company's clinical practices while developing and implementing program protocols for pain management.

Dr. Joyal strengthens the KindlyMD leadership team by overseeing clinical practices, ensuring adherence to the Company's current standards and regulatory approach. He also assists in the development and implementation of advanced pain management programs, quality assurance, and the creation of updated policies and procedures. In addition, Dr. Joyal will play a key role in collaborating with healthcare providers and specialists to ensure comprehensive patient care is offered across the Company's platform.

Tim Pickett, PA-C, KindlyMD founder and CEO, said, "Dr. Joyal brings a wealth of expertise and a commitment to excellence that greatly enhances our clinical operations and patient care. Known for his strong connections in the interventional pain space, he is an advocate for mental health and supportive of medical cannabis treatment. We are excited to welcome Dr. Joyal and look forward to the positive impact he will have on our clinics and the patients we serve."

Dr. Joyal is a licensed physician with board certifications in Anesthesiology, Pain Medicine, and Addiction Medicine. Dr. Joyal graduated from Brigham Young University with a degree in Neuroscience in 2004 and earned his MD from the Medical College of Wisconsin. He specialized in Anesthesiology at Washington University in St. Louis, and further specialized in Pain Medicine through the University of Utah's fellowship program, graduating in 2014. He also offers medication-assisted treatment for opioid addiction.

Dr. Joyal commented, "I am thrilled to join the KindlyMD team and contribute to our shared mission of advancing patient care. My goal is to bring innovative pain management strategies with a compassionate approach to enhance our patients' well-being and overall quality of life, and I look forward to working with the KindlyMD leadership team to achieve this."

About KindlyMD

KindlyMD^TM is a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies to offer patients comprehensive care and reduce the addiction and dependency of opioid use in the U.S. KindlyMD currently operates four centers including the largest alternative pain treatment center in Utah. With a focus on holistic pain management through its specialty outpatient clinical services, including, where appropriate, the recommendation of medical cannabis by KindlyMD healthcare providers, KindlyMD is providing better patient health outcomes.

For more information, please visit www.kindlymd.com.

Forward-Looking Statements

This press release contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified by the use of words such as "should," "may," "intends," "anticipates," "believes," "estimates," "projects," "forecasts," "expects," "plans," and "proposes." These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. You are urged to carefully review and consider any cautionary statements and other disclosures, including, but not limited to, the statements made under the heading "Risk Factors" in KindlyMD, Inc.'s Annual Report on Form 10-K for the fiscal year ended December 31, 2022. KindlyMD, Inc. does not undertake any duty to update any forward-looking statements except as may be required by law. The information which appears on our websites and our social media platforms, including, but not limited to, Instagram and Facebook, is not part of this press release.

Investor Relations Contact:
Valter Pinto, Managing Director
KCSA Strategic Communications
(212) 896-1254
This email address is being protected from spambots. You need JavaScript enabled to view it.